F

Facile Therapeutics

0 followers

Facile Therapeutics is bringing Ebselen into the clinic to demonstrate it will be effective in preventing the recurrence of CDI in a Proof-of-Concept (PoC) clinical trial.

Industries

Employees

1-10

Links

Org chart

Marc Navre's profile picture
Marc Navre
Co-Founder, CEO & CSO
Profile photo

Marc Navre

Collapse
Allan Wagman's profile picture
Allan Wagman
VP of CMC, Consulting Position
  1. Something went wrong loading the org chart, please refresh the page.